Literature DB >> 8116534

Effect of vitamin A supplementation of intravenous lipids on early vitamin A intake and status of premature infants.

S H Werkman1, J M Peeples, R J Cooke, E A Tolley, S E Carlson.   

Abstract

Preterm infants were randomly assigned to receive routine vitamin A supplementation (Regular A) or additional vitamin A in intravenous lipids (High A). Because infants with bronchopulmonary dysplasia (BPD) have poorer vitamin A status than infants who do not develop BPD, High A and Regular A infants were divided by BPD (no or yes) before determining the effects of treatment on intake and plasma concentration of retinol in the first month. Compared with infants without BPD, those with BPD received less retinol (RE.kg-1.d-1) if assigned to Regular A and more if assigned to High A (BPD by vitamin A interaction, P < 0.002). High A-BPD infants compared with Regular A-BPD infants had significantly higher plasma retinol concentrations in the first month. Retinyl palmitate appears to be an effective adjunct to routine vitamin A administration. Infants most likely to benefit from receiving vitamin A in intravenous lipids are those advanced more slowly to full enteral feeding.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8116534     DOI: 10.1093/ajcn/59.3.586

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  10 in total

Review 1.  [Vitamin A level and diseases of premature infants].

Authors:  En-Fu Tao; Tian-Ming Yuan
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2016-02

Review 2.  Vitamin A and preterm infants: what we know, what we don't know, and what we need to know.

Authors:  H Mactier; L T Weaver
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-03       Impact factor: 5.747

Review 3.  Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants.

Authors:  Brian A Darlow; P J Graham; Maria Ximena Rojas-Reyes
Journal:  Cochrane Database Syst Rev       Date:  2016-08-22

4.  Late administration of antenatal vitamin A promotes pulmonary structural maturation and improves ventilation in the lamb model of congenital diaphragmatic hernia.

Authors:  Nicola A Lewis; Bruce A Holm; Jon Rossman; Daniel Swartz; Philip L Glick
Journal:  Pediatr Surg Int       Date:  2011-02       Impact factor: 1.827

5.  Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease.

Authors:  S P Wardle; A Hughes; S Chen; N J Shaw
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-01       Impact factor: 5.747

6.  Vitamin A to prevent bronchopulmonary dysplasia in extremely low birth weight infants: a systematic review and meta-analysis.

Authors:  Shunsuke Araki; Shin Kato; Fumihiko Namba; Erika Ota
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

7.  Vitamin A supplementation prevents the bronchopulmonary dysplasia in premature infants: A systematic review and meta-analysis.

Authors:  Yueqin Ding; Zhifeng Chen; Yanling Lu
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

8.  The effects of early vitamin A supplementation on the prevention and treatment of bronchopulmonary dysplasia in premature infants: a systematic review and meta-analysis.

Authors:  Li Huang; Diqing Zhu; Gaofeng Pang
Journal:  Transl Pediatr       Date:  2021-12

9.  Oral vitamin A supplementation in preterm infants to improve health outcomes: A systematic review and meta-analysis.

Authors:  Nanthida Phattraprayoon; Teerapat Ungtrakul; Kamonwan Soonklang; Paweena Susantitaphong
Journal:  PLoS One       Date:  2022-04-04       Impact factor: 3.240

10.  Early Vitamin A Supplementation for Prevention of Short-Term Morbidity and Mortality in Very-Low-Birth-Weight Infants: A Systematic Review and Meta-Analysis.

Authors:  Yanxiu Ye; Xiaoyan Yang; Jing Zhao; Jianghua He; Xiaoming Xu; Jiao Li; Jing Shi; Dezhi Mu
Journal:  Front Pediatr       Date:  2022-04-07       Impact factor: 3.569

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.